Sign Up to like & get
recommendations!
2
Published in 2023 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2023.1214479
Abstract: that degrades several vasoactive peptides, including natriuretic peptides), on glycemic and metabolic parameters, insulin resistance, and echocardiographic parameters in patients with prediabetes and heart failure with reduced ejection fraction (HFrEF). Their results suggest that sacubitril/valsartan…
read more here.
Keywords:
insights diagnosis;
editorial prediabetes;
risk;
diagnosis risk ... See more keywords